In lung cancer, β-Ele adjuvant treatment could overcome the radioresistance of NSCLC and reverse the epithelial mesenchymal transition and cancer stem cells transdifferentiation induced by radiation via the Prx-1/NF-kB/iNOS pathway [25]. The gene discussed is NFKB1; the disease is lung carcinoma.